摘要:
A system and method for handling data received from an implantable medical device (IMD) is provided. The method includes communicating a device parameter value of an IMD device parameter from the IMD to an external device and determining, at the external device, that the communicated device parameter value is at an improper value. Additionally, in response to the determining that the communicated device parameter value is at an improper value, automatically performing at least one of re-programming the IMD device parameter with a selected substitute device parameter value, ignoring, or purging non-programmable data.
摘要:
Embodiments of the invention are related to systems for interfacing with implantable medical devices, amongst other things. In an embodiment, the invention includes an external medical system including a processor and a telemetry circuit in communication with the processor, the processor configured to communicate with an implanted medical device. The system can be configured to query a system user after a first period of time in which indicators of system use are not detected. The system can be further configured to deactivate one or more data transmission features of the implanted medical device after a second period of time in which one or more indicators of system use are not detected. Other embodiments are also included herein.
摘要:
The present application describes compounds according to Formula I, wherein R1, R2, R3, R4, X and Y are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents.
摘要:
A method, system, and business model are disclosed for supporting handover between a mobile host and a corresponding node located in a heterogeneous network. Handover paths are established to accommodate a plurality of quality of service properties. Admission control is performed that considers the established handover paths and an established first reservation path. Gateways are contacted to determine a handover path to use. The determined handover path is used to support vertical handover. A second reservation path is established while maintaining the first reservation path and the handover path.
摘要:
A compound of formula I wherein W is a bicyclic hetroaryl of the structure X is —O—, —S—, —SO2—, —CHR5—, —CHR5O—, —CHR5S—, —CHR5SO2—, —CHR5CO— or —CH2CHR5—; Y is a bond or —CHR6—; Z is an aryl or heteroaryl group of the following structure: A is —CH— or —N—; B is —O— or —S—; and R1, R2, R3, R4, R5, R6, R7 and R8 are as described herein. Further provided is a method for treating diabetes and related diseases employing a glycogen phosphorylase inhibiting amount of the above compound, either alone or in combination with another therapeutic agent.
摘要:
In a multiservice wireless communication system according to the present invention, a location manager 47 of a multiservice terminal 140 detects its own position with a GPS receiver interface 49. The location manager sends the detected positional information to a management server 110 via a common-signaling wireless network base station 100 in which respective multiple service zones serviced by multiple wireless systems overlap in a common-signaling wireless zone and acquires information on available wireless systems as a response to that. A network selecting section 44 selects a wireless system that most matches selecting conditions from the acquired available wireless systems and performs communication via the interfaces 40 and 41 that operate the selected wireless system.
摘要:
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R6, R7, m and n are described herein.
摘要:
The invention provides for compounds of formula I wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of eating disorders, metabolic disorders, obesity, cognitive disorders, neurological disorders, pain disorders, inflammation disorders, in the promotion of smoking cessation and for the treatment of other psychiatric disorders Also provided are pharmaceutical compositions containing such compounds and pharmaceutical combinations of the compounds of the invention with other therapeutic agents.
摘要:
It is an object of the present invention to provide a sulfonic acid group-containing polymer and a sulfonic acid group-containing aromatic compound, which have excellent proton conductivity even under the low humidification condition, are excellent in mechanical strength and chemical stability and, moreover, can attain high output and excellent physical durability when processed into a solid polymer fuel cell, as well as a polymer electrolyte material, a polymer electrolyte molded product and a solid polymer fuel cell respectively using the same. The sulfonic acid group-containing polymer of the present invention is a sulfonic acid group-containing polymer comprising a constituent unit containing a sulfonic acid group (A1), and a constituent unit not containing a sulfonic acid group (A2), wherein the polymer contains a constituent unit having a specified structure as at least one constituent unit containing a sulfonic acid group (A1) at 25 mol % or more based on a sum of the constituent unit containing a sulfonic acid group (A1). Further, the polymer electrolyte material, polymer electrolyte molded product and solid polymer fuel cell of the present invention are constituted using such a sulfonic acid group-containing polymer.
摘要:
A monitor for determining the operation condition of at least one cable that suffers bending and/or twisting and constitutes an electrical loop and a method thereof are provided. The monitor comprises a test electrical signal generator (5) for generating an identifiable test electrical signal and injecting the test electrical signal into the first point of the at least one cable, a test electrical signal filter (7) adapting to extract the injected test electrical signal from the second point of the at least one cable, and a comparator (8) for comparing a predetermined threshold with the difference between the electrical state of the injected test electrical signal and the extracted test electrical signal and producing a warning signal indicating cable fatigue when the difference exceeds the predetermined threshold. It provides the advantages as follows: it only monitors the electric performance, not the mechanical performance of a cable; it monitors the cable itself rather than a monitor material; it is applicable to all kinds of cables, including but not limited to a large-current cable; it does not introduce new cables; it is an on-line monitoring, i.e. the electro-mechanical system needs no pause for monitoring its cable fatigue.